Company / Return on Assets (ROA)
Integra Lifesciences Holdings Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-14.3%
FY2025
5-year range
-14.3% / 4.6%
FY2021-FY2025
Trend
-8335.3%
vs FY2024
Sector context
#135 of 159
Health Care
What the data says
Return on Assets (ROA) changed -8335% YoY in FY2025, a notable deviation from the 9-year average annual change of -732%.
Based on SEC 10-K filings.
-14.3% in FY2025 with a 5-year CAGR of -18.0%.
Declined from 1.8% to -14.3% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -19.0pp
- 5-Year Change
- -18.0pp
- 10-Year Change
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 159This company -14.3% Sector average -2.2%
▼
-548.3% below sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's return on assets (roa) has declined for 3 consecutive years.
- In FY2025, return on assets (roa) decreased 8335.3% year-over-year.
- Currently 12.1pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -14.3% | -8335.3% |
| FY2024 | -0.2% | -109.5% |
| FY2023 | 1.8% | -61.4% |
| FY2022 | 4.6% | +3.8% |
| FY2021 | 4.5% | +20.8% |
| FY2020 | 3.7% | +143.4% |
| FY2019 | 1.5% | -22.4% |
| FY2018 | 2.0% | +1881.8% |
| FY2017 | -0.1% | -105.9% |
| FY2016 | 1.9% | +1040.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026